Centrally located body fat is related to inflammatory markers in healthy postmenopausal women

Menopause

Volumn 15, Issue 4, 2008, Pages 619-627

  Perry, Courtney D ^a   Alekel, D Lee ^a   Ritland, Laura M ^a   Bhupathiraju, Shilpa N ^a   Stewart, Jeanne W ^a   Hanson, Laura N ^a   Matvienko, Oksana A ^b   Kohut, Marian L ^c   Reddy, Manju B ^a   Van Loan, Marta D ^d   Genschel, Ulrike ^e  

^a Center for Designing Foods to Improve Nutrition   (United States)

^b UNIVERSITY OF NORTHERN IOWA   (United States)

^c IOWA STATE UNIVERSITY   (United States)

^d AGRICULTURAL RESEARCH SERVICE   (United States)

^e E005A Lagomarcino Hall   (United States)

Author keywords

C reactive protein; Cardiovascular disease; Fibrinogen; Interleukin 1 ; Interleukin 6; Tumor necrosis factor

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; FIBRINOGEN; ACUTE PHASE PROTEIN; AUTACOID; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD CELL; BODY COMPOSITION; BODY FAT; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FIBRINOGEN BLOOD LEVEL; GEOGRAPHY; HUMAN; LEUKOCYTE; MENOPAUSE; NORMAL HUMAN; OBESITY; POSTMENOPAUSE; REGRESSION ANALYSIS; ABDOMINAL FAT; BLOOD; BODY MASS; CLINICAL TRIAL; DIET; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL;

ABDOMINAL FAT; ACUTE-PHASE PROTEINS; ADIPOSITY; AGED; BODY MASS INDEX; C-REACTIVE PROTEIN; DIET; FEMALE; FIBRINOGEN; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; INTERLEUKIN-6; MIDDLE AGED; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 51449120037     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e318159f1a2     Document Type: Article

References (49)

1. Grady D. Management of menopausal symptoms. N Engl J Med 355; 2006:2338-2347.
2. Krotkiewski M, Björntorp P, Sjöström L, Smith U. Impact of obesity on metabolism in men and women: importance of regional adipose tissue distribution. J Clin Invest 1983;72:1150-1162.
3. Carr M. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 2003;88:2404-2411.
4. Carr DB, Utzschneider KM, Hull RL, et al. Intra-abdominal fat is a major determinant of the national cholesterol education program adult treatment panel III criteria for the metabolic syndrome. Diabetes 2004;53:2087-2094.
5. De Michele M, Panico S, Iannuzzi A, et al. Association of obesity and central fat distribution with carotid artery wall thickening in middle-aged women. Stroke 2002;33:2923-2928.
6. Kannel WB, Cupples LA, Ramaswami R, Stokes J III, Kreger BE, Higgins M. Regional obesity and risk of cardiovascular disease, the Framingham study. J Clin Epidemiol 1991;44:183-190.
7. Rexrode KM, Hennekens CH, Willett WC, et al. A prospective study of body mass index, weight change, and risk of stroke in women. JAMA 1997;277:1539-1545.
8. Azizi F, Esmailzadeh A, Mirmiran P, Ainy E. Is there an independent association between waist-to-hip ratio and cardiovascular risk factors in overweight and obese women? Int J Cardiol 2005;101:39-46.
9. Klein S, Allison DB, Heymsfield SB, et al. Waist circumference and cardiometabolic risk: a consensus statement from Shaping America's Health: Association for Weight Management and Obesity Prevention; NAASO, The Obesity Society; the American Society for Nutrition; and the American Diabetes Association. Am J Clin Nutr 2007;85:1197-1202.
10. Shoelson SE, Herrero L, Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology 2007; 132:2169-2180.
11. Matsubara M, Maruoka S, Katayose S. Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. Eur J Endocrinol 2002;147:173-180.
12. Katsuki A, Sumida Y, Murashima S, et al. Serum levels of tumor necrosis factor-α are increased in obese patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1998;83:859-862.
13. Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 1998;83: 847-850.
14. Di Renzo L, Bigioni M, Del Gobbo V, et al. Interleukin-1 (IL-1) receptor antagonist gene polymorphism in normal weight obese syndrome: relationship to body composition and IL-1 alpha and beta plasma levels. Pharmacol Res 2007;5:131-138.
15. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunctions: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999;19:972-978.
16. Hirosumi J, Tuncman G, Chang L, et al. A central role for JNK in obesity and insulin resistance. Nature 2002;420:333-336.
17. Pacifici R, Brown C, Puscheck E, et al. Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells. Proc Natl Acad Sci U S A 1991;88:5134-5138.
18. Pottratz ST, Bellido T, Mocharla H, Crabb D, Manolagas SC. 17 beta-Estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism. J Clin Invest 1994;93:944-950.
19. Armour KE, Ralston SH. Estrogen upregulates endothelial constitutive nitric oxide synthase expression in human osteoblast-like cells. Endocrinology 1998;139:799-802.
20. Massafra C, Gioia D, De Felice C, et al. Effects of estrogens and androgens on erythrocyte antioxidant superoxide dismutase, catalase and glutathione peroxidase activities during the menstrual cycle. J Endocrinol 2000;167:447-452.
21. Kelly MJ, Levin ER. Rapid actions of plasma membrane estrogen receptors. Trends Endocrinol Metab 2001;12:152-156.
22. Olsen NJ, Kovacs WJ. Gonadal steroids and immunity. Endocr Rev 1996;17:369-384.
23. Jilka RL, Hangoc G, Girasole G, et al. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 1992;257: 88-91.
24. Ammann P, Rizzoli R, Bonjour JP, et al. Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency. J Clin Invest 1997;99:1699-1703.
25. Maxwell SR. Women and heart disease. Basic Res Cardiol 1998;93: 79-84.
26. Alekel DL, St. Germain A, Peterson CT, Hanson KB, Stewart JW, Toda T. Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women. Am J Clin Nutr 2000;72:844-852.
27. Morabia A, Costanza MC. International variability in ages at menarche, first live birth, and menopause: World Health Organization collaborative study of neoplasia and steroid contraceptives. Am J Epidemiol 1998;148: 1195-1205.
28. Paffenbarger RS, Wing AL, Hyde RT. Physical activity as an index of heart attack risk in college alumni. J Epidemiol 1978;108:161-175.
29. Ainsworth BE, Haskell WL, Whitt MC, et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000;32:S471-S480.
30. Moeller LE, Peterson CT, Hanson KB, Dent SB, Lewis DS, Alekel DL. Isoflavone-rich soy protein prevents loss of hip lean mass but does not prevent the shift in regional fat distribution in perimenopausal women. Menopause 2003;10:322-331.
31. Glickman SG, Marn CS, Supiano MA, Dengel DR. Validity and reliability of dual-energy X-ray absorptiometry for the assessment of abdominal adiposity. J Appl Physiol 2004;97:509-514.
32. Allison PD. Logistic Regression Using the SAS System: Theory and Application. Cary, NC: SAS Institute Inc, 1999.
33. Piche ME, Lemieux S, Weisnagel SJ, Corneau L, Nadeau A, Bergeron J. Relation of high-sensitivity C-reactive protein, interleukin-6, tumor necrosis factor-alpha, and fibrinogen to abdominal adipose tissue, blood pressure, and cholesterol and 34. triglyceride levels in healthy postmenopausal women. Am J Cardiol 2005;96:92-97.
34. Manns PJ, Williams DP, Snow CM, Wander RC. Physical activity, body fat, and serum C-reactive protein in postmenopausal women with and without hormone replacement. Am J Hum Biol 2003;15:91-100.
35. Bassuk SS, Rifai N, Ridker PM. High-sensitivity C-reactive protein: clinical importance. Curr Probl Cardiol 2004;29:439-493.
36. Nicoll CD. In: Tierney LM, McPhee SJ, Papdikis MA, eds. Current Medical Diagnosis and Treatment, 45th ed. Columbus, OH: McGraw-Hill, 2006:1736, 1738.
37. Yom SS, Busch TM, Friedberg JS, et al. Elevated serum cytokine levels in mesothelioma patients who have undergone pleurectomy or extrap-leural pneumonectomy and adjuvant intraoperative photodynamic therapy. Photochem Photobiol 2003;78:75-81.
38. Narbutt J, Lesiak A, Skibinska M, et al. Repeated doses of UVR cause minor alteration in cytokine serum levels in humans. Mediators Inflamm 2005;2005:298-303.
39. Ushiroyama T, Ikeda A, Ueki M. Elevated plasma interleukin-6 (IL-6) and soluble IL-6 receptor concentrations in menopausal women with and without depression. Int J Gynaecol Obstet 2002;79:51-52.
40. Kritchevsky SB, Bush AJ, Pahor M, Gross MD. Serum carotenoids and markers of inflammation in nonsmokers. Am J Epidemiol 2000;152: 1065-1071.
41. DeSouza CA, Stevenson ET, Davy KP, Jones PP, Seals DR. Plasma fibrinogen levels in healthy postmenopausal women: physical activity and hormone replacement status. J Gerontol A Biol Sci Med Sci 1997; 52:M294-M298.
42. DeMott WR. Hematology. In: Jacobs DS, Demott WR, Grady HJ, Horvat RT, Huestis DW, Kasten BL Jr., eds. Laboratory Test Handbook, 4th ed. Hudson, OH: Lexi-Comp Inc.; 1996:338.
43. Womack J, Tien PC, Feldman J, et al. Obesity and immune cell counts in women. Metabolism 2007;56:998-1004.
44. Rudnicka AR, Rumly A, Lowe GDO, Strachan DP. Diurnal, seasonal, and blood-processing patterns in levels of circulating fibrinogen, fibrin D-dimer, C-reactive protein, tissue plasminogen activator, and von Willebrand factor in a 45-year-old population. Circulation 2007;115: 996-1003.
45. Roubenoff R, Harris TB, Abad LW, Wilson PW, Dallal GE, Dinarello CA. Monocyte cytokine production in an elderly population: effect of age and inflammation. J Gerontol A Biol Sci Med Sci 1998;53:M20-M26.
46. Pearson TA, LaCava J, Weil HF. Epidemiology of thrombotic-hemostatic factors and their associations with cardiovascular disease. Am J Clin Nutr 1997;65(Suppl):1674S-1682S.
47. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001;286:327-334.
48. Krauss S, Zhang CY, Lowell BB. The mitochondrial uncoupling-protein homologues. Nat Rev Mol Cell Biol 2005;6:248-261.
49. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996;87:2095-2147.